No title
Aim: Predicting the time-activity curve (TAC) of [177Lu]Lu-DOTA-TATE for organs at risk and neuroendocrine tumours (NETs) is an essential element in the calculation of the absorbed dose (AD) and a critical step for individualising peptide receptor radionuclide therapy (PRRT) treatment planning. This study aims to predict the TAC of [177Lu]Lu-DOTA-TATE using a single quantitative image of [68Ga]Ga-
